Ftse Mib
32.827,93
0,50%
DAX
18.043,30
0,13%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,00%
Bitcoin
65.805,56
-1,25%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Palisade Bio Inc (PALI) Palisade Bio Inc (PALI) Notizie

Palisade Bio Inc

PALI
4,64
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:12
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/6/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202414:30GLOBEPalisade Bio Announces Notice of Allowance for Canadian..
10/6/202415:15GLOBEPalisade Bio to Present at the Virtual Investor Pitch..
31/5/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202421:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:50EDGAR2Form ARS - Annual Report to Security Holders
22/5/202422:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/5/202422:45EDGAR2Form DEF 14A - Other definitive proxy statements
21/5/202414:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
17/5/202422:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202414:05GLOBEPalisade Bio Reports First Quarter 2024 Financial Results..
13/5/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:52EDGAR2Form 8-K - Current report
09/5/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202423:06EDGAR2Form S-3 - Registration statement under Securities Act of..
07/5/202414:30GLOBEPalisade Bio Appoints Margery Fischbein to its Board of..
07/5/202413:30GLOBEPalisade Bio Announces Closing of $4 Million Private..
02/5/202414:30GLOBEPalisade Bio Announces $4 Million Private Placement Priced..
01/5/202414:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
23/4/202414:30GLOBEPalisade Bio Enters into Strategic Collaboration with Strand..
16/4/202414:30GLOBEPalisade Bio Successfully Demonstrates Bioactivation of..
11/4/202415:15GLOBEPalisade Bio to Participate in the Virtual Investor Lunch..
10/4/202414:15GLOBEPalisade Bio Presents Development Overview of PALI-2108 at..
03/4/202423:30GLOBEPalisade Bio Announces 1-for-15 Reverse Stock Split
27/3/202413:00GLOBEPalisade Bio Reports Year End 2023 Financial Results and..
06/3/202422:35EDGAR2Form 8-K - Current report
15/2/202414:35GLOBEPalisade Bio to Present at Digestive Disease Week (DDW) 2024
14/2/202420:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:38EDGAR2Form 8-K - Current report
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:35GLOBEPalisade Bio Provides Corporate Update and Reiterates..
09/2/202422:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202420:40GLOBECorrection Notice of Palisade Bio’s Press Release Announcing..
08/2/202414:05GLOBEPalisade Bio Announces Formation of Clinical Advisory Board..
07/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202423:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
06/2/202416:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 4,64

La tua Cronologia

NASDAQ
PALI
Palisade Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network